Search results
GSK and CureVac to Restructure Collaboration into New Licensing Agreement
Digital Journal· 4 days agoGSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, including combinationsCureVac receives €400 million upfront and ...
Number of pharmacies offering private Covid jab to quadruple by autumn
The i newspaper online iNews· 3 days agoThe number of independent pharmacies offering private Covid jabs is set to quadruple by the autumn...
Lipitor Ruling Raises Class Status Bar in Pay-for-Delay Cases
Bloomberg Law· 4 days ago‘s win against claims the company conspired to hinder the release of a generic cholesterol-reducing drug raises the standard for plaintiffs to win class status in pay-for-delay cases. The denial ...
Opinion: Sometimes conspiracy theorists get things sort of right
The Globe and Mail· 2 days agoJen Gerson is a contributing columnist for The Globe and Mail. Spend too much time arguing on the...